Explore

Reuters Reuters
From diapers to drugs: How India's global corporate hubs are putting AI to work

From diapers to drugs: How India's global corporate hubs are putting AI to work

By Shivansh Tiwary and Praveen Paramasivam May 28 (Reuters) - Whether they are recruiting the ideal "momfluencer" to sell diapers or trawling through reams of data to fast-track drug launches, global centers of multinational firms in India are increasingly putting AI to work in creative ways.
Trendline Trendline
AI Enhances Efficiency in Medical Affairs Teams, Reducing Manual Burden

AI Enhances Efficiency in Medical Affairs Teams, Reducing Manual Burden

AI Enhances Efficiency in Medical Affairs Teams, Reducing Manual Burden
Trendline Trendline
Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development

Eli Lilly Acquires Three Biotech Firms for $3.8 Billion to Boost Vaccine Development
Trendline Trendline
Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions

Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions

Eli Lilly Reenters Infectious Disease Market with $3.8 Billion Acquisitions
Trendline Trendline
AI-Driven Field Reporting Apps Revolutionize Construction Industry Efficiency

AI-Driven Field Reporting Apps Revolutionize Construction Industry Efficiency

AI-Driven Field Reporting Apps Revolutionize Construction Industry Efficiency
Trendline Trendline
Pfizer CEO Albert Bourla's Compensation Rises Amidst Industry Restructuring

Pfizer CEO Albert Bourla's Compensation Rises Amidst Industry Restructuring

Pfizer CEO Albert Bourla's Compensation Rises Amidst Industry Restructuring
Trendline Trendline
Merck KGaA Adopts Veeva Vault CRM for Global Operations, Enhancing Commercial Efficiency

Merck KGaA Adopts Veeva Vault CRM for Global Operations, Enhancing Commercial Efficiency

Merck KGaA Adopts Veeva Vault CRM for Global Operations, Enhancing Commercial Efficiency
Reuters Reuters
China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says

China pharma industry not impacted by Beijing scrutiny of sensitive tech deals, JW chief says

By Andrew Silver SHANGHAI, May 26 (Reuters) - China's booming pharmaceutical industry is not being impacted by Beijing's tightening scrutiny over deals involving sensitive technologies, the CEO of JW Therapeutics said Tuesday. 
Trendline Trendline
Australia Post Partners with Alpha Level to Develop Machine Learning Models for Cybersecurity

Australia Post Partners with Alpha Level to Develop Machine Learning Models for Cybersecurity

Australia Post Partners with Alpha Level to Develop Machine Learning Models for Cybersecurity
Reuters Reuters
CVS brings back coverage for Lilly's obesity drug Zepbound

CVS brings back coverage for Lilly's obesity drug Zepbound

May 28 (Reuters) - CVS Health said on Thursday it will add Eli Lilly's weight-loss drug Zepbound back to some of its drug lists as an additional preferred option for insurance coverage.
Trendline Trendline
AI Enhances Efficiency of Medical Affairs Teams in Pharmaceutical Industry

AI Enhances Efficiency of Medical Affairs Teams in Pharmaceutical Industry

AI Enhances Efficiency of Medical Affairs Teams in Pharmaceutical Industry
Trendline Trendline
Biohub Unveils Advanced Protein Biology Model to Enhance Therapeutic Discovery

Biohub Unveils Advanced Protein Biology Model to Enhance Therapeutic Discovery

Biohub Unveils Advanced Protein Biology Model to Enhance Therapeutic Discovery